查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402593

藥物濫用治療市場：依濫用類型、藥物類型、分銷管道、地區

Drug Abuse Treatment Market, By Abuse Type, By Drug Type, By Distribution Channel, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球藥物濫用治療市場預計將從 2023 年的 357.4 億美元增加到 2030 年的 207 億美元，預測期內年複合成長率(CAGR)為 8.1%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 207億美元
實際資料 2018-2021 預測期 2023-2030
預測期複合年成長率 8.10% 2030年市場規模預測 357.4億美元
圖 1. 2023 年全球市場佔有率(%)（依地區）
藥物濫用治療市場-IMG1

近年來，全球藥物濫用治療市場經歷了顯著成長。藥物濫用疾病的盛行率不斷上升，主要是由於非法藥物的供應增加，以及精神健康問題的盛行率不斷上升，因此需要有效的治療方案。此外，人們對成癮治療的各種藥物和心理治療的認知不斷提高，促使更多的人尋求專業幫助。擴大針對藥物濫用的健康保險覆蓋範圍以及促進治療計劃的各種政府措施也刺激了市場擴張。然而，與毒癮相關的社會恥辱繼續阻止許多患者積極尋求可用的治療方案。

市場動態：

全球藥物濫用治療市場主要是由全球藥物濫用疾病的流行所推動的。最近的估計表明，到 2023 年，全球將有超過 3,100 萬人受到藥物濫用障礙的影響。由於販運網路的興起和社會接受度的提高，毒品的供應量增加，促使消費率上升。此外，憂鬱症和焦慮等心理健康問題的增加往往導致個人產生藥物依賴，這也使治療提供者受益。針對古柯鹼、酒精、鴉片類藥物和大麻成癮的各種藥物和心理治療也推動了需求。然而，門診復健計畫對許多患者來說費用昂貴，財務限制是主要的阻礙因素。缺乏社會支持也是一些地區成功復原的障礙。然而，政府透過有利的法規和宣傳宣傳活動提供的支持為市場的持續成長提供了有利的機會。

本研究的主要特點

  • 該報告對全球藥物濫用治療市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 本報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 本報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球藥物濫用治療市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球藥物濫用治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球藥物濫用治療市場的各種策略矩陣來促進決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 新藥開發
    • 與藥物濫用相關的社會恥辱
    • 市場相關人員策略合作
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章全球藥物濫用治療市場－冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球藥物濫用治療市場，依濫用類型，2018-2030 年

  • 酒精成癮
  • 煙草/尼古丁成癮
  • 鴉片類藥物成癮

第6章全球藥物濫用治療市場，依藥物類型，2018-2030

  • Disulfiram
  • Acamprosate
  • 納曲酮
  • 美沙酮
  • Buprenornhine
  • 尼古丁成癮的治療
  • 尼古丁替代療法
  • 非尼古丁藥物
  • 其他

第7章 全球藥物濫用治療市場，依通路，2018-2030 年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章全球藥物濫用治療市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭形勢

  • 公司簡介
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan NV
    • Odyssey Pharmaceuticals Inc.
    • Lil'Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics

第10章

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI2011

Global drug abuse treatment market is expected to reach US$ 20.70 Bn by 2030, from US$ 35.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 20.70 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 35.74 Bn
Figure 1. Global Drug Abuse Treatment Market Share (%), By Region, 2023
Drug Abuse Treatment Market - IMG1

Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.

Market Dynamics:

Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.

Key features of the study:

  • This report provides in-depth analysis of the global drug abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global drug abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., and British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, Dr. Reddy's Laboratories, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market

Detailed Segmentation:

  • Global Drug Abuse Treatment Market, By Abuse Type
    • Alcohol Dependence
    • Tobacco/Nicotine Addiction
    • Opioid Addiction
  • Global Drug Abuse Treatment Market, By Drug Type
    • Disulfiram
    • Acamprosate
    • Naltrexone
    • Methadone
    • Buprenorphine
    • Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
    • Non-Nicotine Medication
    • Bupropion
    • Varenicline
    • Others
  • Global Drug Abuse Treatment Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Drug Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Drug Abuse Treatment Market:
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Abuse Type
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet ,By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Novel drug development
    • Social stigma associated with drug abuse
    • Strategic collaboration between market players
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Drug Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Abuse Treatment Market, By Abuse Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alcohol Dependence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Tobacco/Nicotine Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Opioid Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Drug Abuse Treatment Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Disulfiram
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acamprosate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Naltrexone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Methadone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Buprenorphine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Addiction Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
  • Non-Nicotine Medication
    • Bupropion
    • Varenicline
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Drug Abuse Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Drug Abuse Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • Cipla Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us